Intrathecal (IT) trastuzumab (T) for the treatment of leptomeningeal disease (LM) in patients (pts) with human epidermal receptor-2 positive (HER2+) cancer: A multicenter phase 1/2 study Meeting Abstract
| Authors: | Kumthekar, P.; Lassman, A. B.; Lin, N.; Grimm, S.; Gradishar, W.; Pentsova, E.; Jeyapalan, S.; Groves, M.; Melisko, M.; Raizer, J. |
| Abstract Title: | Intrathecal (IT) trastuzumab (T) for the treatment of leptomeningeal disease (LM) in patients (pts) with human epidermal receptor-2 positive (HER2+) cancer: A multicenter phase 1/2 study |
| Meeting Title: | Society for Neuro-Oncology Inaugural Conference on Brain Metastases |
| Journal Title: | Neuro-Oncology Advances |
| Volume: | 1 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Aug 16-17 |
| Meeting Location: | New York, NY |
| ISSN: | 2632-2498 |
| Publisher: | Oxford University Press |
| Date Published: | 2019-08-01 |
| Start Page: | i6 |
| Language: | English |
| DOI: | 10.1093/noajnl/vdz014.025 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: LPTO-02 |
